Pfizer begins study of Covid jabs updated to match Omicron variant

(Yui Mok/PA)
(Yui Mok/PA)
Tue, 25 Jan, 2022 - 12:21
Associated Press reporters

Pfizer has begun a study comparing its original Covid-19 vaccine with doses specially tweaked to match the hugely contagious Omicron variant.

Pfizer and its partner BioNTech announced the study on Tuesday.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Poison Alcohol treatment cases up 19% since 2022, report shows 
Irish athletes proud to 'honour the gift' of organ donation with 14 gold medals at European Transplant Games Irish athletes proud to 'honour the gift' of organ donation with 14 gold medals at European Transplant Games
School stock Q&A: What is the primary school survey and what does it mean for children and parents?
CoronavirusPfizer#COVID-19Place: International
<p>The organisation said that while AI offers significant opportunities, the absence of robust safeguards risks leaving children exposed to harmful content, exploitation, and manipulation in online environments. File picture </p>

Children facing 'very real danger' from rapid development of AI

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited